Flash point testing determines the minimum temperature at which a liquid gives off enough vapor to become ignited near its surface. To determine a liquid’s flash point, a sample is heated, often while stirring, until a nearby ignition source is able to ignite the vapors. For samples with particularly low flash points, refrigeration is often […]
Company Announcements Cobalt Light Systems opened a US subsidiary in Reston, Virginia, in November 2014. FOSS 2014 revenues declined 2.2% but grew more than 2% organically to DKK 1.72 billion ($306.4 million) (see page 12). In March, ANDalyze named VWR as a distributor of its DNAzyme-based heavy metal–testing products. Product Introductions Konica Minolta announced in […]
Company Announcements INFICON fourth quarter 2014 Emergency Response & Security sales rose 23.1% to $13.3 million. In 2014, segment sales grew 32.0% to $35.9 million to account for 12% of revenues, due largely to government spending in North America. First quarter segment revenue declined 55.7% to $3.9 million. In February, Alpha MOS announced the creation […]
Company Announcements Half-year sales for Abcam rose 7.7%, 13.8% in constant currency, to £66.7 million ($107.6 million) (see IBO 3/31/15). Product sales grew 10.4%, 16.7% excluding currency, to £62.7 million ($101.2 million). Sales of core and RabMAb primary antibodies grew 13.3% and 19.4% excluding currency to make up 68% and 15% of Product revenue, respectively. […]
Company Announcements In March, Qlucore partnered with TATAA Biocenter, which will use Qlucore’s Omics Explorer Software for providing NGS data analysis and for training courses. Illumina formed a collaboration with Merck Serono to develop a universal NGS-based oncology diagnostic. The assays will be used to detect and measure multiple variants simultaneously to support clinical trials. […]
The Life Science Sales Index article in the March 15 issue of IBO excluded a summary of Tecan results. For the second half of 2014, Tecan sales grew 10.2%, 5.8% organically, to CHF 227.5 million ($242.0 million = CHF 0.94 = $1). The acquisition of IBL (see IBO 7/31/14) contributed 4.5% to sales growth. Currency […]
The Korea National Food Cluster, or Foodopolis, will be built in Iksan, South Korea, and open by June 2016. It will be the site of R&D for about 150 food companies. The center is expected to create 22,000 jobs and generate $14 billion in processed and value-added products each year. Three R&D facilities are planned: […]
This month, Canada released its Economic Action Plan 2015. Starting in 2017, the Canada Foundation for Innovation will receive CAD 1.33 billion ($1.09 billion) over six years for research infrastructure at hospitals and universities. Over six years, federal labs and research facilities will get CAD 380 million for repairs and upgrades. Beginning in 2016, the […]
International backing of about $4.5 million will enable the formation of the Alliance for Accelerating Excellence in Science in Africa (AESA), planned for June. The Alliance will direct African science programs and manage research focusing on the continent. Much of the research funding in Africa is from international funders, which determine how it is spent. […]
The US FDA has finalized its 2012 drafts on biosimilarity with three guidance documents. The first guidance presents the approach for sponsors to obtain evidence showing biosimilarity and by the FDA in reviewing applications for biosimilars. It also provides some clarifications in its recommendations. It encourages frequent consultation with the FDA during the early stages […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
